Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immunotech Biopharm Ltd ( (HK:6978) ) has provided an announcement.
Immunotech Biopharm has called its annual general meeting for 30 April 2026 in Beijing, where shareholders will review and adopt the audited consolidated financial statements and directors’ and auditor’s reports for the year ended 31 December 2025. The meeting will also consider the re-election of executive, non-executive and independent non-executive directors, approval of directors’ remuneration, re-appointment of Deloitte Touche Tohmatsu as auditor, and the granting of a general mandate to the board to issue up to 20% of the company’s existing share capital.
These resolutions, particularly the broad share issuance mandate, are standard governance steps that give management flexibility to raise capital and pursue strategic initiatives without convening separate shareholder meetings for each transaction. The re-election of the current board line-up and the continued engagement of a major international auditor also signal continuity in corporate oversight and financial reporting, which may reassure investors about the company’s governance stability and its capacity to finance future growth in the highly capital-intensive biotech sector.
The most recent analyst rating on (HK:6978) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on Immunotech Biopharm Ltd stock, see the HK:6978 Stock Forecast page.
More about Immunotech Biopharm Ltd
Immunotech Biopharm Ltd is a biopharmaceutical company listed in Hong Kong, focusing on the research, development and commercialization of immunotherapy and related biotech treatments. The company operates primarily in mainland China, leveraging its Beijing base to advance innovative biological products for domestic and potentially broader Asian healthcare markets.
Average Trading Volume: 304,807
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.68B
Learn more about 6978 stock on TipRanks’ Stock Analysis page.